HopeStage
Back to all studies
TerminatedNCT00998608

Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia

Medication studyAges 18–55Taiwan
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

Listed locations
Kaohsiung CitySee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateAugust 2007
Recruitment status
Terminated
Enrollment listed in the registry
88
Sponsor
Kaohsiung Kai-Suan Psychiatric Hospital
Sponsor type
Hospital / academic medical center
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
Taiwan
Age range
From 18 Years to 55 Years
Official registry ID
NCT00998608
Official title
Show the full official title

A Randomized, Double-Blind, Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Combined With Low Dose of Haloperidol in the Treatment of Schizophrenic Disorder

Recruitment & locations

Terminated

Kaohsiung City

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Kaohsiung Kai-Suan Psychiatric Hospital, a hospital or academic medical center.

Does this study involve medication?

Yes. The study involves medication, including risperidone.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies